Drugs / Tongxinluo capsule
Tongxinluo capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06112028 | Oct 2023 → Nov 2025 overdue | — | Yanbin Li | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongxinluo capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06112028 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine” NCT06112028 ↗ |